Edition:
India

Mersana Therapeutics Inc (MRSN.OQ)

MRSN.OQ on NASDAQ Stock Exchange Global Select Market

5.69USD
2:29am IST
Change (% chg)

$-0.61 (-9.68%)
Prev Close
$6.30
Open
$6.34
Day's High
$6.51
Day's Low
$5.56
Volume
25,374
Avg. Vol
43,663
52-wk High
$23.67
52-wk Low
$5.56

Chart for

About

Mersana Therapeutics, Inc. is a biotechnology company. The Company is focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design... (more)

Overall

Beta: --
Market Cap(Mil.): $429.84
Shares Outstanding(Mil.): 22.71
Dividend: --
Yield (%): --

Financials

Mersana's cancer drug trial put on hold by FDA; shares halted

Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on partial hold by the U.S. Food and Drug Administration after a patient's death was possibly linked to the treatment.

19 Jul 2018

Mersana Therapeutics cancer drug trial on partial hold by FDA

July 19 Mersana Therapeutics said on Thursday its early-stage trial for its cancer drug has been put on partial hold by the U.S. health regulator after a patient's death was possibly related to the treatment.

19 Jul 2018

Earnings vs. Estimates